Goldberg Law PC announces that it is investigating claims of potential misrepresentations by Horizon Pharma plc. The investigation focuses on whether the company and its officers violated securities laws by issuing misleading information to investors.
The investigation concerns whether the company violated the Securities Exchange Act of 1934.
On October 19, 2015, the New York Times published an article called “Drug Makers Sidestep Barriers on Pricing.” The article stated that certain drug manufacturers, including Horizon, have begun using specialty pharmacies “to circumvent efforts of insurers and pharmacists to switch patients to generic components, or even to the over-the-counter versions.”
If you have any questions concerning your legal rights in this case, contact Goldberg Law PC at 800-977-7401, visit their website, or email them at firstname.lastname@example.org.